Increasing Cost-effectiveness of Inpatient Treatment of Affective Disorders

NCT00662428 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 202

Last updated 2012-06-21

No results posted yet for this study

Summary

The cost-effectiveness of a new, guideline oriented sequential inpatient - outpatient treatment model will be investigated. Secondary outcomes are: patient satisfaction, practitioners' satisfaction and influence on work.

Conditions

  • Depressive Disorder

Interventions

OTHER

Symptom based discharge management

Depressive symptoms of patients are weekly assessed by Beck Depression Inventory (BDI II). Patients are discharged when BDI-score is under 20 points. Patients are treated in the same hospital for two more weeks as outpatients before being referred to outpatient care (general practitioner or specialist).

OTHER

Treatment as usual

Treatment as usual is the usual stationary depression treatment which consists of a combination of several psychopharmacological and psychotherapeutical treatments. Duration of treatment is varying widely.

Sponsors & Collaborators

  • German Medical Association

    collaborator OTHER
  • University Hospital Freiburg

    lead OTHER

Principal Investigators

  • Martin Härter, Prof. Dr. Dr. · Freiburg University Medical Center, Dept. of Psychiatry and Psychotherapy

  • Isaac Bermejo, Dr. · Freiburg University Medical Center, Dept. of Psychiatry and Psychotherapy

  • Lars P Hölzel, Dr. · Freiburg University Medical Center, Dept. of Psychiatry and Psychotherapy

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-05-31
Primary Completion
2010-09-30
Completion
2011-08-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00662428 on ClinicalTrials.gov